Bone growth drug benefits children with dwarfism

A drug that boosts bone growth in children with achondroplasia — the most common form of dwarfism — may also reduce their chances of SIDS, sleep apnoea and needing surgery.

Related Keywords

Australia ,Japan ,United Kingdom ,Australian ,Ravi Savarirayan ,Murdoch Children Research Institute ,Lancet Child Adolescent Health ,Murdoch Children ,Research Institute ,Professor Ravi Savarirayan ,Biomarin Pharmaceutical ,Lancet Child ,Adolescent Health ,Australian Government ,Dwarfism ,Achondroplasia ,Drug ,Vosoritide ,Murdoch Childrens Research Institute ,Cri ,